𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Magnetic resonance angiography and use of contrast agents

✍ Scribed by Hartnell, GeorgeG.

Book ID
123034703
Publisher
The Lancet
Year
1992
Tongue
English
Weight
178 KB
Volume
339
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Magnetic resonance angiography of the ra
Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents
✍ Torsten Reese; Damien Bochelen; AndrΓ© Sauter; Nicolau Beckmann; Markus Rudin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 595 KB

We describe and discuss the application of three-dimensional (3D) time-of-flight (TOF) magnetic resonance angiography (MRA) to visualize non-invasively the cerebral vasculature of the rat. MR angiograms of healthy spontaneously hypertensive rats were obtained without the use of contrast agents. Tota

Evaluation of radiofrequency pulses and
Evaluation of radiofrequency pulses and contrast agent doses for use in 3D pulmonary magnetic resonance angiography
✍ Sandra S. Halliburton; Cynthia B. Paschal; John D. Rothpletz πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 244 KB

Ten healthy volunteers were imaged with breath-hold, three-dimensional (3D) time-of-flight (TOF) magnetic resonance angiography (MRA) using single-variable-angle uniform signal excitation (VUSE), double-VUSE, and flat radiofrequency (RF) pulses with various doses of contrast agent. The ability of ea

Combined use of the intravascular blood-
Combined use of the intravascular blood-pool agent, gadomer, and carbon dioxide: A novel type of double-contrast magnetic resonance angiography (MRA)
✍ Robbert M. Maes; Jonathan S. Lewin; Jeffrey L. Duerk; Frank K. Wacker πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 487 KB πŸ‘ 1 views

## Abstract ## Purpose To evaluate the combined use of carbon dioxide (CO~2~) and a gadolinium‐based blood‐pool agent for magnetic resonance angiography (MRA). ## Materials and Methods After an initial intravenous injection of the blood‐pool agent Gadomer (Schering AG, Germany), repeated transca